Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Tellado

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Infectious Diseases|July 29, 2000
In vivo neutrophil dysfunction in cirrhotic patients with advanced liver diseaseC Fiuza, M Salcedo, G Clemente, et al.
Zentralblatt Fur Chirurgie|January 1, 1989
The anergic state as a predictor of pancreatic sepsisJ L García-Sabrido, E Valdecantos, E Bastida, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1990
Anergic patients before elective surgery have enhanced nonspecific host-defense capacityJ M Tellado, B Giannias, B Kapadia, et al.
Annals of Surgery|January 1, 1989
Predicting mortality based on body composition analysisJ M Tellado, J L Garcia-Sabrido, J A Hanley, et al.
International Journal of Antimicrobial Agents|November 17, 2012
Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE studyJ J De Waele, J M Tellado, J Alder, et al.
Radiologia|August 27, 2022
Expert recommendations about the use of gadoxetic acid in patients with liver metastases in SpainJ Borrego Gómez, N Romera, J M Tellado, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|September 1, 2005
[Guidelines for the empirical antibiotic treatment of intraabdominal infections]J M Tellado, A Sitges-Serra, F Barcenilla, et al.
Annals of Surgery|April 1, 1996
A clinical trial on the prevention of catheter-related sepsis using a new hub modelM Segura, F Alvarez-Lerma, J M Tellado, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyK Reinhart, T Menges, B Gardlund, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Infectious Diseases|July 29, 2000
In vivo neutrophil dysfunction in cirrhotic patients with advanced liver diseaseC Fiuza, M Salcedo, G Clemente, et al.
Zentralblatt Fur Chirurgie|January 1, 1989
The anergic state as a predictor of pancreatic sepsisJ L García-Sabrido, E Valdecantos, E Bastida, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1990
Anergic patients before elective surgery have enhanced nonspecific host-defense capacityJ M Tellado, B Giannias, B Kapadia, et al.
Annals of Surgery|January 1, 1989
Predicting mortality based on body composition analysisJ M Tellado, J L Garcia-Sabrido, J A Hanley, et al.
International Journal of Antimicrobial Agents|November 17, 2012
Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE studyJ J De Waele, J M Tellado, J Alder, et al.
Radiologia|August 27, 2022
Expert recommendations about the use of gadoxetic acid in patients with liver metastases in SpainJ Borrego Gómez, N Romera, J M Tellado, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|September 1, 2005
[Guidelines for the empirical antibiotic treatment of intraabdominal infections]J M Tellado, A Sitges-Serra, F Barcenilla, et al.
Annals of Surgery|April 1, 1996
A clinical trial on the prevention of catheter-related sepsis using a new hub modelM Segura, F Alvarez-Lerma, J M Tellado, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyK Reinhart, T Menges, B Gardlund, et al.
Pageof 2